Date |
Title |
Category |
22-Jul-2010 |
The statement warned: "Contraindicated In Children Under 2 Years of Age" that must be filled in the package insert of all products carbocysteine, acetylcarbocysteine and methylcarbocysteine (Mecysteine)
Bil (54) dlm. BPFK/PPP/01/03 dated 22nd Jul 2010
|
DCA letters |
25-May-2010 |
The Full evaluation launch module of QUEST3
Bil (45) dlm. BPFK/PPO/03/02 Bhg 3 dated 25th May 2010
|
DCA letters |
14-Apr-2010 |
Rules and regulation drug control regulations and cosmetics 1984 (Amendment 2006). Instruction numbers for two years in 2010. NPCB Circular on
Bil (49) dlm. BPFK/PPP/01/03 dated 14th April 2010
|
DCA letters |
14-Sep-2010 |
Products use on the male/female genitals for sexual purposes which is not categories as cosmetic classification
Bil (41) dlm. BPFK/17/K/2.2 dated 14th Sept 2009
|
DCA letters |
23-Feb-2011 |
PhAMA: NKEA - Pemandu Steering committee mtg - 22nd Feb 2011 @ 10 a.m
|
General News |
14-Feb-2012 |
PhAMA Press Release on the 'Launching of the PhAMA Industry Fact Book, officiated by the Minister of Health, Y.B. Dato' Sri Liow Tiong Lai
Hilton KL
|
General News |
12-May-2010 |
PhAMA participated in the NKEA Workshop organized by PEMANDU.
On 12 May 2010 at the Malaysia Airlines Academy, PhAMA participated in the National Key Economic Areas (NKEA)...
|
General News |
23-Feb-2011 |
PhAMA Annual Games 2011
|
General News |
23-Feb-2011 |
PhAMA 39th AGM Notice - 31 March 2011
|
General News |
25-May-2010 |
NPCB Circular on Quest 3 launch
Bil (49) dlm. BPFK/PPO/03/02 dated 25th May 2010
|
NPCB |
04-Mar-2015 |
News Coverage on GST Media Roundtable
|
General News |
14-Jun-2011 |
MyIPO-PhAMA IP Seminar on Intellectual Property: 'The Way Forward' - Post event Videos and Photos
The MyIPO-PhAMA IP Seminar on Intellectual Property: "The Way Forward", was held on Tuesday 14 June 2011 at the...
|
|
14-Jun-2011 |
Joint MyIPO-PhAMA Seminar on '1 Malaysia Medicines: The Way Forward in Intellectual Property'
MyIPO Office, Level 12A, Menara UOA, Jalan Bangsar Utama 1, Bangsar, Kuala Lumpur
|
|
15-Mar-2016 |
Introduction and List of PhAMA Training Premises for Provisionally Registered Pharmacist (PRP)
|
General News |
16-Aug-2010 |
Cosmetic products that are use around the eye and packaging that are not permitted for the product.
Bil (40) dlm. BPFK/17/K/2.2 dated 16th Aug 2010
|
DCA letters |
13-Oct-2009 |
Caution Statement on “Severe Drug Interaction Between Colchicine and P-Glycoprotein or Strong CYP3A4 Inhibitors” required to be included in the product package insert for Colchicine
Bil (44) dlm. BPFK/PPP/01/03 dated 13th October 2009
|
DCA letters |
14-Sep-2009 |
Caution Statement on “Potential for an Increase in Risk of Suicidal Thoughts or Behaviours” required to be included in the product package insert for Antiepileptik.
Bil (43) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
|
DCA letters |
14-Sep-2009 |
Caution Statement on “Potential For an increase in risk of Hepatotoxicity” required to be included in the product package insert for Propylthiouracil
Bil (41) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
|
DCA letters |
14-Sep-2009 |
Caution Statement on “Potential For an increase in risk of Hepatotoxicity” required to be included in the product package insert for Propylthiouracil
Bil (41) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
|
DCA letters |
14-Sep-2009 |
Caution Statement on “Possible Interaction between Clopidogrel and Proton Pump Inhibitors” required to be included in the product package insert for Clopidogrel
Bil (42) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
|
DCA letters |